To this end, we employed multiple GBM cell lines (U373 and A172), which both displayed SERPINE1 upregulation in the dispersive cell population (Figure 1D, Supplementary Figure S3B), and have different endogenous SERPINE1 expression levels (Supplementary Figure S4A). The gene discussed is SERPINE1; the disease is glioblastoma.